Jun 17, 2021 07:06AM
Jun 17, 2021 07:00AM
May 6, 2021 08:34AM
May 6, 2021 08:30AM
May 6, 2021 08:00AM
May 5, 2021 07:00AM
Apr 30, 2021 10:00AM Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
Apr 16, 2021 08:30AM
Apr 16, 2021 08:03AM
Apr 16, 2021 08:00AM
Apr 5, 2021 08:36AM
Apr 5, 2021 08:30AM
Mar 30, 2021 07:34AM
Mar 30, 2021 07:30AM Horizon Therapeutics plc to Resupply Market With TEPEZZA® (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Beginning in April
Mar 29, 2021 10:05AM
Mar 22, 2021 08:51AM
Mar 15, 2021 08:50AM
Feb 24, 2021 07:08AM
Feb 24, 2021 07:00AM
Feb 1, 2021 09:30AM
Feb 1, 2021 07:03AM Horizon Therapeutics (HZNP) to Acquire Viela Bio (VIE) for $53 Per Share in $3.05 Billion Deal
Feb 1, 2021 07:00AM
Jan 11, 2021 07:04AM
Jan 11, 2021 07:00AM
Dec 17, 2020 01:25PM
Dec 17, 2020 06:40AM
Nov 13, 2020 08:34AM
Nov 13, 2020 08:30AM New Data Build on Growing Evidence Supporting TEPEZZA® (teprotumumab-trbw) Efficacy in Thyroid Eye Disease (TED), Including in Patients With Less Severe Disease and Longer Disease Duration
Nov 2, 2020 07:00AM
Nov 2, 2020 06:58AM
Oct 30, 2020 08:00AM
Oct 20, 2020 08:00AM
Oct 14, 2020 08:03AM
Oct 14, 2020 08:00AM
Oct 5, 2020 08:00AM Horizon Therapeutics plc Announces TEPEZZA® (teprotumumab-trbw) Selected as a Winner of the R&D 100 Award
Aug 5, 2020 07:00AM
Jul 31, 2020 07:12AM
Jul 31, 2020 07:00AM
Jul 9, 2020 08:39AM
Jul 9, 2020 08:30AM
Jul 9, 2020 08:00AM
May 14, 2020 09:04AM Horizon Therapeutics (HZNP) Announces New Data on Pharmacokinetic Profile of TEPEZZA Reinforce Labeled Dosing Regimen, Indicating Positive, Consistent Response to Therapy
May 14, 2020 09:00AM
May 6, 2020 07:00AM
Apr 27, 2020 08:10AM
Apr 2, 2020 08:11AM
Apr 2, 2020 08:00AM
Mar 31, 2020 12:03PM
Mar 31, 2020 12:00PM TEPEZZA™ (teprotumumab-trbw) Significantly Reduces Proptosis (Eye Bulging), a Key Marker of Thyroid Eye Disease, Across Patient Subtypes
Feb 28, 2020 10:00AM

151,867 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All